Viridian Therapeutics, Inc./DE
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $47.4M | $22.1M | $21.2M | $5.1M | $209.0K |
| Accounts Receivable | $1.5M | $20.0K | $394.0K | $1.1M | $994.0K |
| Inventory | — | $64.0K | $187.0K | $179.0K | $357.0K |
| Total Current Assets | $51.9M | $23.9M | $11.7M | $6.8M | $2.1M |
| Property, Plant & Equipment | $563.0K | $625.0K | $1.2M | $1.2M | $928.0K |
| Goodwill | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — |
| Total Assets | $52.5M | $24.8M | $12.9M | $8.1M | $3.7M |
| Liabilities | |||||
| Accounts Payable | $906.0K | $1.0M | $242.0K | $255.0K | $100.0K |
| Total Current Liabilities | $3.9M | $6.9M | $2.5M | $2.0M | $27.3M |
| Long-Term Debt | $10.0M | — | — | — | — |
| Total Liabilities | $14.0M | $9.7M | $58.2M | $2.1M | $27.6M |
| Stockholders' Equity | |||||
| Retained Earnings | $-93.6M | $-67.1M | $-18.0M | $-6.6M | — |
| Total Stockholders' Equity | $38.5M | $-61.9M | $-45.3M | $6.0M | $-23.9M |